Doctor profile · Federal record

Dr. Matthew McMahon, M.D.

Gastroenterology Physician (CMS: Gastroenterology) · Omaha, NE

  • NPI 1528244845
  • Accepts Medicare
  • 21 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
8901 Indian Hills Dr, Suite 200
Omaha, NE 681144029
(402) 397-7057

Credentials & registration

NPPES · NUCC
NPI registered
January 2008 — 18 yrs on file
Profile last updated
June 29, 2011
Year of graduation
2005 — 21 yrs since
Specialty taxonomy
207RG0100X — NUCC code
State license (1)
Nebraska #26153
Medicaid
NE #47077295213

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1528244845. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
12,265
Distinct HCPCS
10
Medicare allowed
$381,022
HCPCS Description Services Patients Avg allowed
J3380 Injection, vedolizumab, 1 mg 9,300 28 $22
J1745 Injection, infliximab, excludes biosimilar, 10 mg 1,920 27 $32
45380 Biopsy of large bowel using a flexible endoscope 213 212 $96
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare 140 139 $228
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope 125 122 $97
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes 117 73 $72
99213 Established patient office or other outpatient visit, 20-29 minutes 103 82 $83
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes 58 57 $120
99214 Established patient office or other outpatient visit, 30-39 minutes 51 45 $116
43450 Dilation of esophagus 49 49 $35

In context: peer comparison

Among 25 peers in Omaha Gastroenterology Physician, average services per provider: 429. This provider delivers 29× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,115
Transactions
78
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Aimmune Therapeutics, INC. 4 $822.82
Janssen Biotech, INC. 21 $319.62
Abbvie INC. 18 $266.51
Lilly USA, LLC 5 $102.66
Genzyme Corporation 4 $88.64
Madrigal Pharmaceuticals 4 $77.55
Gilead Sciences, INC. 3 $76.58
Salix Pharmaceuticals, A Division of Bausch Health US, LLC 4 $76.14
Takeda Pharmaceuticals U.S.A., INC. 3 $75.97
Organon LLC 3 $43.32
Ironwood Pharmaceuticals, INC 2 $38.69
Ipsen Biopharmaceuticals, INC 2 $35.90
Intercept Pharmaceuticals, INC. 2 $31.52
Regeneron Healthcare Solutions, INC. 2 $27.18
Celgene Corporation 1 $16.54

By nature of payment

Food and Beverage
$2,115

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,010
Patients
358
Total drug cost
$128,892
Drug Type Claims Patients Total cost
Omeprazole Generic 235 59 $3,470
Peg 3350-Electrolyte (Sodium Chloride/Nahco3/Kcl/Peg) Brand 180 179 $4,464
Pantoprazole Sodium Generic 120 35 $1,432
Dicyclomine Hcl Generic 76 19 $2,345
Sucralfate Generic 62 25 $5,856
Dexlansoprazole Dr (Dexlansoprazole) Brand 61 11 $16,039
Colestipol Hcl Generic 59 19 $9,008
Nortriptyline Hcl Generic 40 0 $435
Metoclopramide Hcl Generic 36 11 $450
Ondansetron Odt (Ondansetron) Brand 36 0 $667

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Matthew McMahon's medical specialty?
Dr. Matthew McMahon practices Gastroenterology Physician in Omaha, NE.
Where does Dr. Matthew McMahon practice?
Dr. Matthew McMahon practices at 8901 Indian Hills Dr, Omaha, NE 681144029. Office phone: 4023977057.
What is Dr. Matthew McMahon's NPI?
Dr. Matthew McMahon's National Provider Identifier (NPI) is 1528244845, issued by NPPES.
Does Dr. Matthew McMahon accept Medicare assignment?
Yes. Dr. Matthew McMahon accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Matthew McMahon commonly perform?
Top Medicare-reported procedures in 2023: Injection, vedolizumab, 1 mg (HCPCS J3380); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745); Biopsy of large bowel using a flexible endoscope (HCPCS 45380). Source: CMS Medicare Physician & Other Practitioners file.